Leading Oncology Experts to Converge in Pune for 3rd Biennial Conference of Oncology Group of Pune (OGP)
OGP 2026 to focus on Peritoneal Surface Oncology, Gynaecologic Cancers, CRS, HIPEC and emerging treatment approaches
Pune, September 2026: The 3rd Biennial Conference of the Oncology Group of Pune (OGP 2026) on Peritoneal Surface Oncology and Gynaecologic Oncology will be held on 18 and 19 September 2026 at Hyatt Regency Pune, including a pre conference cadaveric workshop on 17 September at Symbiosis Skills lab bringing together leading national and international experts in oncology to discuss advances in the diagnosis and treatment of complex and advanced cancers. The conference will provide a dedicated academic platform for clinicians to exchange expertise, discuss emerging evidence and explore innovative, multidisciplinary approaches to cancer care. (OGP 2026)
The information was given by Dr. Debanshu Bhaduri President Oncology Group of Pune (OGP) and Senior Surgical Oncologist MN Budhrani Cancer Institute, Pune, Dr. Rakesh Neve, Surgical Oncologist Sterling Hospital, Pune, Dr. Nagesh Sirsath, Medical Oncologist Ruby Hall Clinic, Pune along with organising secretaries Dr. Snita Sinukumar, Surgical Oncologist Apollo Hospital, Pune and Dr. Tushar Patil, Medical Oncologist
Sahyadri Hospital, Pune at a press conference.
Executive Committee for the OGP conference include Dr. Shailesh Naik, Surgical Oncologist Indrayani Hospital, Pune, Dr. Vidita Powle, Surgical Oncologist
Apollo Hospital, Pune, Dr. Nagesh Sirsath, Medical Oncologist Ruby Hall Clinic, Pune, Dr. Shweta Mutha, Radiation Oncologist Apollo Hospital, Pune
Dr. Anup Tamankar, Surgical Oncologist Deenanath Mangeshkar Hospital Pune, Dr. Rakesh Neve, Surgical Oncologist Sterling Hospital, Pune, Dr. Jayant Gawande,Medical Oncologist Aditya Birla Hospital, Pune and Dr. Rahul Kulkarni, Medical Oncologist Deenanath Mangeshkar Hospital.
The conference will bring together experts in peritoneal surface malignancies, ovarian cancer, gastrointestinal cancers with peritoneal spread, cytoreductive surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), gynaecologic oncology and newer treatment modalities.
A key focus of OGP 2026 will be the management of cancers involving the peritoneal surface, which often present complex clinical challenges and require highly specialised, multidisciplinary treatment. The scientific programme will feature expert lectures, panel discussions, case-based deliberations and interactive sessions, enabling participants to discuss challenging clinical situations and evolving treatment strategies.
The conference will feature eminent international experts including Prof. Paul Sugarbaker, Ex-Chief of Peritoneal Surface Malignancy, MedStar Washington Hospital Center, USA; Prof. Olivier Glehen, Professor of GI and Peritoneal Surface Malignancy Surgery, Hospices Civils de Lyon, France; Prof. Artem Stepanyan, Head, Gynecologic Oncology Service, Nairi Medical Center, Armenia; and Prof. Lana Bijelic, Chief, Peritoneal Surface Malignancies Unit, CHU Moisés Broggi, Barcelona, Spain and Academic Coordinator, European School of Peritoneal Surface Oncology (ESPSO).
Advances in cancer treatment are increasingly demonstrating that selected patients with certain advanced Stage IV malignancies may benefit from aggressive, multimodal treatment approaches. In appropriately selected patients and tumour types, strategies such as cytoreductive surgery combined with HIPEC can offer the possibility of long-term disease control and, in some cases, potentially curative outcomes.
The conference will underscore the importance of a multidisciplinary, patient-centred approach to cancer care. Specialists from surgical oncology, medical oncology, radiation oncology, gynaecologic oncology, pathology, radiology, anaesthesiology and allied healthcare disciplines will come together to discuss how collaborative decision-making can improve outcomes for patients with complex cancers.